1-4 of 4
Joaquin Díaz-Mediavilla
Close
Sort by
Journal Articles

Value of Gene Expression Profiling by Taqman® Low Density Arrays in the Diagnosis and Prognosis of Acute Myeloid Leukemia.

Carmen Chillon, Carlos Santamaria, Ramon Garcia-Sanz, Montserrat Hernandez, Norma C. Gutiérrez, Dolores Caballero, Maria-Belén Vidriales, Cristina Pérez, Ana Balanzategui, Miguel Alcoceba, Maria E. Sarasquete, Noemi Puig, Fernando Ramos, Alfonso García de Coca, Joaquin Díaz-Mediavilla, J.F San Miguel, Marcos Gonzalez
Journal: Blood
Blood (2009) 114 (22): 1620.
https://doi.org/10.1182/blood.V114.22.1620.1620
Published: 2009
Journal Articles

Thalidomide / Dexamethasone (TD) Vs. Bortezomib (Velcade) â /Thalidomide / Dexamethasone (VTD) Vs. VBMCP/VBAD/Velcade â as Induction Regimens Prior Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma (MM): Results of a Phase III PETHEMA/GEM Trial.

Laura Rosiñol, Ma Teresa Cibeira, Joaquin Martinez, Maria Victoria Mateos, Albert Oriol, Ma José Terol, Jose García-Laraña, Dolores Hernández, Javier de la Rubia, Anna Sureda, Juan Besalduch, Luis Palomera, Yolanda Gonzalez, Ma Asuncion Echebeste, Joaquin Díaz-Mediavilla, Felipe de Arriba, Adrian Alegre, Miguel T Hernández, Juan José Lahuerta, J.F F San Miguel, Joan Blade
Journal: Blood
Blood (2009) 114 (22): 130.
https://doi.org/10.1182/blood.V114.22.130.130
Published: 2009
Journal Articles

Screening Thousands of Drugs in Leukemia Patient Samples to Identify Novel Uses for Approved Drugs.

Teresa A Bennett, Ph.D., Sandra Sapia, MD., Pathologist, Daniel Primo, PhD, Lilia Suarez, Santiago Lago, PhD, Maria Matoses, PhD, Ana Espinosa, PhD, Consuelo Tudela, PhD, Elena Arroyo, PhD, William Coyt Jackson, PhD, Alex Okun, PhD, Horacio Hector Lopez, PhD, Isolde Gornemann, MD, Eva Diez, PhD, Josep M Roma, MD, Jose Luis Dapena, MD, Soledad Gallego Melcon, MD, Jose Sanchez de Toledo, MD, Ana Rosell, MD, Santiago Del Castillo, MD, PhD, Alicia Bailen, MD, Ana Isabel Heiniger, MD, Joaquin Díaz-Mediavilla, MD, Felipe Prosper, MD, Manuel Ramirez Sr., MD, PhD, Macarena Ortiz, MD, Marcos González, MD, Alfonso Dominguez-Gil, MD, Iñaki F Troconiz, MD, Fernando Rodriguez de Fonseca, MD, PhD, Enrique M Ocio, MD, Andrew Saunders, MD, Julieta Montejo, MD, Luis Caveda, PhD, Alberto Orfao, MD, PhD, Joan Ballesteros, PhD
Journal: Blood
Blood (2009) 114 (22): 4414.
https://doi.org/10.1182/blood.V114.22.4414.4414
Published: 2009
Journal Articles

ERG, EVI1 and PRAME Are Relevant Markers of Treatment Response and Survival, and They Could Be Useful for Improving the Risk-Stratification in Citogenetically Normal Acute Myeloid Leukemia (CN-AML)

Carlos Santamaría, Carmen Chillón, Ramon García-Sanz, Cristina Pérez, Fernando Ramos, Alfonso García de Coca, Jose- Maria Alonso, Pilar Giraldo, Teresa Bernal, José-Antonio Queizán, José Nicolas Rodríguez, Pascual Fernández-Abellán, Abelardo Barez, María-José Peñarrubia, Mari Luz Amigo, Alejandro Martín García-Sancho, Miguel Angel Pozas, Ana Balanzategui, Joaquin Díaz-Mediavilla, Jesús F. San Miguel, Marcos González
Journal: Blood
Blood (2008) 112 (11): 4844.
https://doi.org/10.1182/blood.V112.11.4844.4844
Published: 2008